About Eptinezumab
Class: | Monoclonal antibody (CGRP antagonist)
Use: | Preventive treatment of migraine in adults
Adult dose: | 100 mg administered as an intravenous infusion once every 3 months; may be increased to 300 mg based on clinical response
Pediatric dose: | Safety and efficacy not established in pediatric patients under 18 years of age
Side effects: | Nasopharyngitis, injection site reactions, hypersensitivity reactions, constipation
Contraindications: | Hypersensitivity to eptinezumab or any
Drug Class
Monoclonal antibody (CGRP antagonist)
Uses & Indications
Preventive treatment of migraine in adults
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; may be stored at room temperature (up to 25°C or 77°F) for up to 7 days
Manufacturer & Packaging
Manufacturer: H. Lundbeck A/S, DENMARK
Package Size
1 GLASS VIAL ( 1 ML )
Price & Supplier
Price in UAE: AED 6688.50
Dosage Information
Adult Dose
100 mg administered as an intravenous infusion once every 3 months; may be increased to 300 mg based on clinical response
Pediatric Dose
Safety and efficacy not established in pediatric patients under 18 years of age
Side Effects
Nasopharyngitis, injection site reactions, hypersensitivity reactions, constipation
Contraindications & Precautions
Hypersensitivity to eptinezumab or any component of the formulation
Important Warnings
Risk of hypersensitivity reactions; monitor for signs of anaphylaxis; not recommended for use in patients with a history of hypersensitivity to any components of the product
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.